You Might Like
Covaxin showed better antibody response in 2-18 year olds than adults: Bharat BiotechIndiaTimes - Published | |
'Precautionary dose' for 60+ with comorbidities 9 months after 2nd dose - Check new guidelinesBharat Biotech's Covaxin has been granted approval for restricted use in an emergency situation in the age group between 12 and 18 years.DNA - Published | |
Documents required to register children between 15-18 years on CoWIN App - Complete list hereMeanwhile, Bharat Biotech received the nod from the DGCI for emergency use of vaccines in children above the age of 12 years.DNA - Published | |
BREAKING: Bharat Biotech gets DGCI approval for emergency vaccination for kids aged 12-18Amid rising cases of Omicron in India, DGCI has given Bharat Biotech a green signal for the emergency use of its vaccine for kids aged between 12 to 18 years.DNA - Published | |
Bharat Biotech seeks DCGI's nod for its intranasal COVID-19 booster dose clinical trialsThe company is hoping for early approval for the trails of the intranasal COVID-19 booster given the fast spread of the Omicron variant.DNA - Published Also reported by •IndiaTimes | |
Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: MoS HealthThe current vaccine production capacity of Covishield, manufactured by the Serum Institute of India, is approximately 250-275 million doses per month while it is about 50-60 million doses per month for..IndiaTimes - Published | |
Lancet Infectious Diseases study compare well with phase 3 clinical trials of Covaxin: Bharat BiotechCommenting on the study of the Lancet Infectious Diseases on the effectiveness of Covaxin (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well..IndiaTimes - Published | |
Canada set to recognise Covaxin from Nov 30In a big relief to travellers from India, Canada will recognise Bharat Biotech's Covaxin from November 30. It has expanded its list of WHO-approved Covid-19 vaccines that will be accepted for travel to..IndiaTimes - Published | |
Lost 10 years of life in 18 months due to Covaxin stress, says Krishna EllaIn a face-to-face interview, Ella opened up to TOI about the thrill of developing India’s first indigenous Covid-19 vaccine, but also spoke about the dangers and controversies that dogged the company..IndiaTimes - Published | |
Bharat Biotech's Covaxin safe, 77.8% effective against symptomatic COVID-19: LancetThe findings published by Lancet show Covaxin has 77.8% efficacy against symptomatic COVID-19 and a 63.6% protection against asymptomatic patients.DNA - Published | |
When should you take booster shot of COVID-19 vaccine? Bharat Biotech Chairman says THISBharat Biotech is also looking at nasal vaccine as a booster dose, Chairman and Managing Director Krishna Ella said.DNA - Published | |
Covid: Booster dose of vaccine required if virus gets mutated, says Bharat Biotech ChairmanPeople will need booster doses of the Covid-19 vaccine if the virus gets mutated, said chairman and MD of Bharat Biotech, Dr Krishna Ella. "If there is a mutated Covid-19 virus then a booster is..IndiaTimes - Published | |
UK to add Bharat Biotech's Covaxin to approved vaccine list from November 22The UK will be approving Bharat Biotech's Covaxin for its updated vaccine list for international travelers from November 22.DNA - Published | Covid-19: Govt to start vaccination for kids only after nod to CovaxinChildren may have to wait for some more time to get vaccinated against Covid-19 as the government will start immunisation for kids only after Bharat Biotech's Covaxin is approved for use which might..IndiaTimes - Published |
UK to recognise Covaxin from Nov 22; US welcomes inclusion of Bharat Biotech vaccine in WHO-approved listThe UK has said it will recognise made-in-India Covaxin starting November 22, while the US Centers for Disease Control and Prevention (CDC) on Monday described the World Health Organization’s..IndiaTimes - Published | Bharat Biotech's US partner Ocugen seeks Covaxin approval for childrenCovaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.DNA - Published Also reported by •IndiaTimes |
Bharat Biotech's US partner Ocugen files EUA request with FDA for paediatric use of CovaxinIndiaTimes - Published | Travellers vaccinated with Bharat Biotech's Covaxin can now enter USCovaxin developed by Hyderabad-based Bharat Biotech in partnership with the Indian Council of Medical Research has a 78% efficacy rate against COVID.DNA - Published |
How WHO nod for Bharat Biotech's Covaxin will benefit Indians - Know hereWHO has approved Bharat Biotech's Covaxin for emergency use listing yesterday, and this move can be beneficial for many Indians.DNA - Published | Bharat Biotech gets DCGI nod for shelf-life extension of its COVID-19 vaccine CovaxinBharat Biotech had submitted its data to the drug regulator and sought a shelf-life extension for its vaccine.DNA - Published |
WHO approves Bharat Biotech's Covaxin for emergency use listingWHO has added Bharat Biotech's vaccine Covaxin to the portfolio of vaccines validated by it for the prevention of COVID-19.DNA - Published Also reported by •IndiaTimes | Covaxin gets shelf life extension up to 12 monthsVaccine maker Bharat Biotech on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of Covid-19 vaccine Covaxin up to 12 months from the date..IndiaTimes - Published |
Bharat Biotech's Covaxin likely to get WHO's emergency use approval todayThe decision regarding the emergency usage approval of Bharat Biotech's Covaxin will most likely be issued today by WHO.DNA - Published | Bharat Biotech submits additional data to WHO, decision on Covaxin likely on November 3The Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order..IndiaTimes - Published |
WHO panel to decide on Covaxin EUL tomorrowThe Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order..IndiaTimes - Published | Australia recognises Covaxin, to allow visitors jabbed with it; Modi thanks Oz counterpartAustralia will recognise Covaxin, apart from Covishield, allowing those fully jabbed with the Bharat Biotech vaccine entry into the country. While WHO’s emergency use listing for Covaxin is awaited,..IndiaTimes - Published |
COVID-19: Bharat Biotech's Covaxin recognized by Australia for travel purposesAustralia has given approval to Bharat Biotech's Covaxin for travel purposes in the country, mainly to assist workers and students.DNA - Published | Cannot play with lives of people by directing revaccination with Covishield without any data: SC"We cannot play with the lives of people by directing Centre to revaccinate. We don't have any data with us. We have read in newspapers that Bharat Biotech has filed an application with the World..IndiaTimes - Published |
Bharat Biotech submitting Covaxin data 'regularly, very quickly': WHO heaps praiseTechnical advisory group of World Health Organisation will reconvene on November 2 for final risk-benefit assessment of Bharat Biotech's Covaxin EUL.DNA - Published | We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EULIndia's Bharat Biotech has been submitting data on the EUL of Covaxin "regularly and very quickly" to a technical committee which hopes to have a final recommendation to the WHO next week, a top..IndiaTimes - Published |
CDC lifts US travel hurdles for Covaxin trial participants by putting it on qualifying vaccine list under exceptionsAt a time when the World Health Organisation (WHO) is dithering on granting Emergency Use Listing (EUL) to Bharat Biotech’s Covaxin, the United States Centres for Disease Control and Prevention (CDC)..IndiaTimes - Published | Covaxin yet to get EUL, WHO seeks 'additional clarifications' from Bharat BiotechThe Covaxin jab has been approved in 14 countries and 70 million doses have been distributed overseas, Bharat Biotech told World Health Organisation.DNA - Published |
Review of Covaxin by WHO underway; expect a recommendation within 24 hours: SpokespersonHyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing (EUL). "If the committee is..IndiaTimes - Published | We are waiting for DCGI approval for children's Covid-19 vaccine: Bharat Bitoech ChairmanChairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the Covid-19 vaccine for..IndiaTimes - Published |
WHO's technical advisory group to meet on Oct 26 to take call on Covaxin EULIn a tweet late on Sunday night, World Health Organisation (WHO) chief scientist Soumya Swaminathan said, "WHO has been working closely with Bharat Biotech to complete the dossier. Our goal is to have..IndiaTimes - Published | Covaxin's approval for children aged 2-18 years under experts' opinion, evaluation: SourcesThe final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday. Earlier on Tuesday, official sources had..IndiaTimes - Published |
India resumes vaccine exports as domestic stocks build up: OfficialsOne million shots of Covaxin produced by Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said. Vaccines have also been sent to Nepal, a government source said, adding that..IndiaTimes - Published | Bharat Biotech submits clinical trial data of Covaxin in children to CDSCOIndiaTimes - Published |
WHO nod likely for Covaxin this monthThe World Health Organisation’s approval for emergency use listing (EUL) of Bharat Biotech’s Covaxin is expected to take a few more weeks to arrive. The decision, however, will be taken in October..IndiaTimes - Published | WHO to take final call on Covaxin EUL next weekThe World Health Organisation (WHO) will be taking a final call on Bharat Biotech’s Emergency Use Listing (EUL) application for India’s first indigenously developed Covid-19 vaccine Covaxin next..IndiaTimes - Published |
Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19The Centre has received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19, according to official documents. Serum..IndiaTimes - Published | Month after month, Covaxin missing production targetHomegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine...IndiaTimes - Published |
Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairmanCovaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing..IndiaTimes - Published | Covaxin kids trial over, Bharat Biotech to submit data to DCGI next weekIndiaTimes - Published |
Covaxin may soon get WHO approval as expert group scheduled to meet next monthSAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.DNA - Published | Bharat Biotech awaits feedback from WHO for Covid-19 vaccine Covaxin's emergency use listingIndiaTimes - Published |
AIIMS Delhi to conduct phase 2/3 clinical trials for Bharat Biotech's nasal COVID vaccineDelhi AIIMS is one of the three hospitals where the phase 2 and 3 trials of Bharat Biotech's intranasal vaccine will be conducted.DNA - Published Also reported by •IndiaTimes | First batch of Covaxin rolls out of Gujarat plant of Bharat BiotechIndiaTimes - Published |
